Risks of N95 Face Mask Use in Subjects With COPD

References

1. 1.↵
   Air quality guidelines global update 2005: particulate matter, ozone, nitrogen dioxide and sulfur dioxide. World Health Organization Regional Office for Europe; 2006. Available at: http://www.who.int/iris/handle/10665/107823. Accessed June 3, 2019.
2. 2.↵
   Review of evidence on health aspects of air pollution: REVIHAAP Project. World Health Organization Regional Office for Europe; 2013. Available at: http://www.euro.who.int/en/health-topics/environment-and-health/air-quality/publications/2013/review-of-evidence-on-health-aspects-of-air-pollution-revihaap-project-final-technical-report. Accessed June 3, 2019.
3. 3.↵
   Ambient air pollution: a global assessment of exposure and burden of disease. Geneva: World Health Organization; 2016. Available at: https://www.who.int/phe/publications/air-pollution-global-assessment/en/. Accessed June 3, 2019.
4. 4.↵
   1. Dockery DW,
   2. Pope CA III.,
   3. Xu X,
   4. Spengler JD,
   5. Ware JH,
   6. Fay ME,
   7. et al

   . An association between air pollution and mortality in six U.S. cities. N Engl J Med 1993;329(24):1753–1759.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.
   1. Pope CA III.,
   2. Dockery DW

   . Health effects of fine particulate air pollution: lines that connect. J Air Waste Manag Assoc 2006;56(6):709–742.

   OpenUrlCrossRefPubMedWeb of Science
6. 6.
   1. Thurston GD,
   2. Kipen H,
   3. Annesi-Maesano I,
   4. Balmes J,
   5. Brook RD,
   6. Cromar K,
   7. et al

   . A joint ERS/ATS policy statement: what constitutes an adverse health effect of air pollution? An analytical framework. Eur Respir J 2017;49(1). pii: 1600419.

   OpenUrlAbstract/FREE Full Text
7. 7.↵
   1. Pope CA III.,
   2. Burnett RT,
   3. Thun MJ,
   4. Calle EE,
   5. Krewski D,
   6. Ito K,
   7. Thurston GD

   . Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA 2002;287(9):1132–1141.

   OpenUrlCrossRefPubMedWeb of Science
8. 8.
   1. Schikowski T,
   2. Adam M,
   3. Marcon A,
   4. Cai Y,
   5. Vierkötter A,
   6. Carsin AE,
   7. et al

   . Association of ambient air pollution with the prevalence and incidence of COPD. Eur Respir J 2014;44(3):614–626.

   OpenUrlAbstract/FREE Full Text
9. 9.
   1. Gan WQ,
   2. FitzGerald JM,
   3. Carlsten C,
   4. Sadatsafavi M,
   5. Brauer M

   . Associations of ambient air pollution with chronic obstructive pulmonary disease hospitalization and mortality. Am J Respir Crit Care Med 2013;187(7):721–727.

   OpenUrlCrossRefPubMedWeb of Science
10. 10.
    1. Guarnieri M,
    2. Balmes JR

    . Outdoor air pollution and asthma. Lancet 2014;383(9928):1581–1592.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Ko FW,
    2. Tam W,
    3. Wong TW,
    4. Chan DP,
    5. Tung AH,
    6. Lai CK,
    7. Hui DS

    . Temporal relationship between air pollutants and hospital admissions for chronic obstructive pulmonary disease in Hong Kong. Thorax 2007;62(9):780–785.

    OpenUrlAbstract/FREE Full Text
12. 12.↵
    1. Raaschou-Nielsen O,
    2. Andersen ZJ,
    3. Beelen R,
    4. Samoli E,
    5. Stafoggia M,
    6. Weinmayr G,
    7. et al

    . Air pollution and lung cancer incidence in 17 European cohorts: prospective analyses from the European Study of Cohorts for Air Pollution Effects (ESCAPE). Lancet Oncol 2013;14(9):813–822.

    OpenUrlCrossRefPubMedWeb of Science
13. 13.↵
    1. MacIntyre EA,
    2. Gehring U,
    3. Mölter A,
    4. Fuertes E,
    5. Klümper C,
    6. Krämer U,
    7. et al

    . Air pollution and respiratory infections during early childhood: an analysis of 10 European birth cohorts within the ESCAPE Project. Environ Health Perspect 2014;122(1):107–113.

    OpenUrlPubMedWeb of Science
14. 14.↵
    1. Harber P,
    2. Barnhart S,
    3. Boehlecke BA,
    4. Beckett WS,
    5. Gerrity T,
    6. Mcdiarmid MA,
    7. et al

    . Respiratory protection guidelines. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, March 1996. Am J Respir Crit Care Med 1996;154(4 Pt 1):1153–1165.

    OpenUrlCrossRefPubMedWeb of Science
15. 15.↵
    1. Langrish JP,
    2. Mills NL,
    3. Chan JK,
    4. Leseman DL,
    5. Aitken RJ,
    6. Fokkens PH,
    7. et al

    . Beneficial cardiovascular effects of reducing exposure to particulate air pollution with a simple facemask. Part Fibre Toxicol 2009;6:8.

    OpenUrlCrossRefPubMed
16. 16.
    1. Rengasamy A,
    2. Zhuang Z,
    3. Berryann R

    . Respiratory protection against bioaerosols: literature review and research needs. Am J Infect Control 2004;32(6):345–354.

    OpenUrlCrossRefPubMedWeb of Science
17. 17.↵
    1. Radonovich LJ Jr.,
    2. Simberkoff MS,
    3. Bessesen MT,
    4. Brown AC,
    5. Cummings DAT,
    6. Gaydos CA,
    7. et al

    . N95 respirators vs medical masks for preventing influenza among health care personnel: a randomized clinical trial. JAMA 2019;322(9):824–833.

    OpenUrlCrossRef
18. 18.↵
    1. Cherrie JW,
    2. Apsley A,
    3. Cowie H,
    4. Steinle S,
    5. Mueller W,
    6. Lin C,
    7. et al

    . Effectiveness of face masks used to protect Beijing residents against particulate air pollution. Occup Environ Med 2018;75(6):446–452.

    OpenUrlAbstract/FREE Full Text
19. 19.↵
    1. Laumbach R,
    2. Meng Q,
    3. Kipen H

    . What can individuals do to reduce personal health risks from air pollution? J Thorac Dis 2015;7(1):96–107.

    OpenUrlPubMed
20. 20.↵
    1. Langrish JP,
    2. Li X,
    3. Wang S,
    4. Lee MM,
    5. Barnes GD,
    6. Miller MR,
    7. et al

    . Reducing personal exposure to particulate air pollution improves cardiovascular health in patients with coronary heart disease. Environ Health Perspect 2012;120(3):367–372.

    OpenUrlCrossRefPubMedWeb of Science
21. 21.↵
    1. Bourassa S,
    2. Bouchard PA,
    3. Lellouche F

    . Impact of gas mask on work of breathing, breathing patterns, and gas exchange in healthy subjects. Respir Care 2018;63(11):1350–1359.

    OpenUrlAbstract/FREE Full Text
22. 22.↵
    1. Roberge RJ,
    2. Coca A,
    3. Williams WJ,
    4. Powell JB,
    5. Palmiero AJ

    . Physiological impact of the N95 filtering facepiece respirator on healthcare workers. Respir Care 2010;55(5):569–577.

    OpenUrlAbstract/FREE Full Text
23. 23.↵
    1. Lim EC,
    2. Seet RC,
    3. Lee KH,
    4. Wilder,
    5. Smith EP,
    6. Chuah BY,
    7. Ong BK

    . Headaches and the N95 face‐mask amongst healthcare providers. Acta Neurol Scand 2006;113(3):199–202.

    OpenUrlCrossRefPubMedWeb of Science
24. 24.↵
    Guidance for physicians: on assessment of medical fitness to use respirators in conditions of high air quality health index. Hong Kong Medical Association, Labour Department, Department of Health, Environmental Protection Department; 2013. December. Available at: https://www.epd.gov.hk/epd/english/envir_standards/non_statutory/files/Guidance_for_Physicians_eng_2013.pdf. Accessed by June 3, 2019.
25. 25.↵
    1. Vestbo J,
    2. Hurd SS,
    3. Agusti AG,
    4. Jones PW,
    5. Vogelmeier C,
    6. Anzueto A,
    7. et al

    . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013;187(4):347–365.

    OpenUrlCrossRefPubMedWeb of Science
26. 26.↵
    1. Bansal S,
    2. Harber P,
    3. Yun D,
    4. Liu D,
    5. Liu Y,
    6. Wu S,
    7. et al

    . Respirator physiological effects under simulated work conditions. J Occup Environ Hyg 2009;6(4):221–227.

    OpenUrlCrossRefPubMed
27. 27.↵
    1. Harber P,
    2. Santiago S,
    3. Bansal S,
    4. Liu Y,
    5. Yun D,
    6. Wu S

    . Respirator physiologic impact in persons with mild respiratory disease. J Occup Environ Med 2010;52(2):155–162.

    OpenUrlPubMed
28. 28.
    1. Harber P,
    2. Santiago S,
    3. Wu S,
    4. Bansal S,
    5. Liu Y,
    6. Yun D

    . Subjective response to respirator type: effect of disease status and gender. J Occup Environ Med 2010;52(2):150–154.

    OpenUrlPubMed
29. 29.↵
    1. Raven PB,
    2. Jackson AW,
    3. Page K,
    4. Moss RF,
    5. Bradley O,
    6. Skaggs B

    . The physiological responses of mild pulmonary impaired subjects while using a “demand” respirator during rest and work. Am Ind Hyg Assoc J 1981;42(4):247–257.

    OpenUrlPubMed
30. 30.↵
    1. Laferty EA,
    2. McKay RT

    . Physiologic effects and measurement of carbon dioxide and oxygen levels during qualitative respirator fit testing. J Chem Health Saf 2006;13(5):22–28.

    OpenUrl
31. 31.↵
    1. Roberge RJ,
    2. Kim JH,
    3. Powell JB

    . N95 respirator use during advanced pregnancy. Am J Infect Control 2014;42(10):1097–1100.

    OpenUrlPubMed
32. 32.↵
    1. Tong PS,
    2. Kale AS,
    3. Ng K,
    4. Loke AP,
    5. Choolani MA,
    6. Lim CL,
    7. et al

    . Respiratory consequences of N95-type mask usage in pregnant healthcare workers—a controlled clinical study. Antimicrob Resist Infect Control 2015;4:48. eCollection 2015. Erratum in: Antimicrob Resist Infect Control. 2016;5:e26.

    OpenUrl
33. 33.↵
    1. Roberge RJ

    . Physiological burden associated with the use of filtering facepiece respirators (N95 masks) during pregnancy. J Womens Health (Larchmt) 2009;18(6):819–826.

    OpenUrlPubMed
34. 34.↵
    1. Lee HP,
    2. Wang de Y

    . Objective assessment of increase in breathing resistance of N95 respirators on human subjects. Ann Occup Hyg 2011;55(8):917–921.

    OpenUrlCrossRefPubMed